A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

The "personalized cancer vaccines" (PCVs) used by the nine patients in the trial were targeted to genes specific to their ...

A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

Doctors at Dana-Farber say this personalized vaccine can be given after surgery to remove a tumor and train the body’s immune ...

The advent of vaccinations came when a scientist, by the name of Edward Jenner, discovered that an individual exposed to a ...

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell ca ...

Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...